written on 01.04.2014

Actavis shells out $100M for Thai generics maker in bid for Southeast Asia growth


Actavis has bagged its latest catch. Fresh off last month's deal to buy Forest Laboratories in a $25 billion deal, the generics maker forked over a much smaller amount–$100 million–to buy a small generics company in Thailand.